BioInvent International AB is pocketing around SEK150 million (US$21.2 million) - before expenses - and making two prominent additions to its shareholders' register, via a directed offering of 5,434,800 shares.

Comments from EU Health Chief Designate Has Industry on Edge

By Nuala Moran

Wednesday, January 20, 2010

Buy Reprint

No Abstract

Wellcome Trust Offers Bonanza of Sequencing, Genome Data

By Nuala Moran

Wednesday, January 20, 2010

Buy Reprint

No Abstract

BioMedPartners Closes $102M Fund for Early- Mid-Stage EU Companies

By Cormac Sheridan

Wednesday, January 20, 2010

Buy Reprint

No Abstract

BioWorld

Store

Others

BioWorld-International-2010-01-20

U.S. Scientific Inventory Shows Asia, EU Gaining in R&D Status

40 UK Companies Will Share in £8.3M Stem Cell Program

Rapid U.S. Biomedical Research Funding Is Dead: JAMA Report

Other News To Note

BioInvent to Get $21M in Directed Share Offer with Little Discount

Comments from EU Health Chief Designate Has Industry on Edge

Wellcome Trust Offers Bonanza of Sequencing, Genome Data

BioMedPartners Closes $102M Fund for Early- Mid-Stage EU Companies

Explore BioWorld.com

BioWorld

Store

Others

Login to Your Account

BioWorld

Store

Others

BioWorld-International-2010-01-20

Explore BioWorld.com

BioWorld

Store

Others